Bure frees up more than SEK 410M through the sale of Nycomed

Bure frees up more than SEK 410M through the sale of Nycomed We refer to our news release of 30 October when we announced that Nordic Capital has made an agreement to sell the Danish pharmaceutical company, Nycomed, to a company owned by CSFB Private Equity, Blackstone Capital Partners and NIB Private Equity NV. The transaction has been completed and means that Bure frees up more than SEK 410M and reports a capital gain of approximately SEK 300M. Gothenburg, 27 December 2002 Bure Equity AB (publ) For further information, please contact: Iréne Axelsson, Head of Corporate Communications +46 706-32 81 83 www.bure.se ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/12/27/20021227BIT00040/wkr0001.doc http://www.waymaker.net/bitonline/2002/12/27/20021227BIT00040/wkr0002.pdf

wkr0001.doc

wkr0002.pdf